161 related articles for article (PubMed ID: 7506357)
1. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo.
Cole J; Skopek TR
Mutat Res; 1994 Jan; 304(1):33-105. PubMed ID: 7506357
[No Abstract] [Full Text] [Related]
2. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 4. Spontaneous mutations in germ cells of the mouse: estimates of mutation frequencies and a molecular characterization of mutagenic events.
Favor J
Mutat Res; 1994 Jan; 304(1):107-18. PubMed ID: 7506351
[No Abstract] [Full Text] [Related]
3. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 2. Spontaneous mutations in mammalian cells.
Glickman BW; Saddi VA; Curry J
Mutat Res; 1994 Jan; 304(1):19-32. PubMed ID: 7506355
[TBL] [Abstract][Full Text] [Related]
4. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 5. Impact of the molecular spectrum of mutational lesions on estimates of germinal gene-mutation rates.
Mohrenweiser H
Mutat Res; 1994 Jan; 304(1):119-37. PubMed ID: 7506352
[TBL] [Abstract][Full Text] [Related]
5. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 1. Spontaneous mutation: some conceptual difficulties.
Bridges BA
Mutat Res; 1994 Jan; 304(1):13-7. PubMed ID: 7506353
[No Abstract] [Full Text] [Related]
6. International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 6. Estimation of genetic risks of exposure to chemical mutagens: relevance of data on spontaneous mutations and of experience with ionizing radiation.
Sankaranarayanan K
Mutat Res; 1994 Jan; 304(1):139-58. PubMed ID: 7506354
[TBL] [Abstract][Full Text] [Related]
7. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/5: mutagenesis in mammalian cells.
Howard-Flanders P
Mutat Res; 1981 May; 86(3):307-27. PubMed ID: 7029263
[TBL] [Abstract][Full Text] [Related]
8. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
Jansen JD
Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
[TBL] [Abstract][Full Text] [Related]
9. Mutational pattern and frequency of induced nucleotide changes in mouse ENU mutagenesis.
Takahasi KR; Sakuraba Y; Gondo Y
BMC Mol Biol; 2007 Jun; 8():52. PubMed ID: 17584492
[TBL] [Abstract][Full Text] [Related]
10. International Commission for Protection Against Environmental Mutagens and Carcinogens. Spontaneous mutation and its place in risk assessment for chemical mutagens. Report of an ICPEMC Committee.
Bridges BA; Cole J; Favor J; Glickman BW; Mohrenweiser H; Sankaranarayanan K; Skopek TR
Mutat Res; 1994 Jan; 304(1):3-11. PubMed ID: 7506356
[No Abstract] [Full Text] [Related]
11. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/1: Perspectives in mutation epidemiology. 1. Incidence and prevalence of genetic disease (excluding chromosomal aberrations) in human populations.
Matsunaga E
Mutat Res; 1982 Jul; 99(1):95-128. PubMed ID: 6289095
[TBL] [Abstract][Full Text] [Related]
12. NSAID use and somatic exomic mutations in Barrett's esophagus.
Galipeau PC; Oman KM; Paulson TG; Sanchez CA; Zhang Q; Marty JA; Delrow JJ; Kuhner MK; Vaughan TL; Reid BJ; Li X
Genome Med; 2018 Feb; 10(1):17. PubMed ID: 29486792
[TBL] [Abstract][Full Text] [Related]
13. International Commission for Protection Against Environmental Mutagens and Carcinogens. Series: Current issues in mutagenesis and carcinogenesis, No. 39.
Brusick DJ
Mutat Res; 1993 Dec; 319(4):243-4. PubMed ID: 7504196
[No Abstract] [Full Text] [Related]
14. Molecular characterization of mutation and comparison of mutation profiles in the hprt gene of Chinese hamster ovary cells treated with benzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, 1-nitrobenzo[a]pyrene trans-7,8-diol-anti-9,10-epoxide, and 3-nitrobenzo[a]pyrene trans-7,8- diol-anti-9,10-epoxide.
Zhan DJ; Heflich RH; Fu PP
Environ Mol Mutagen; 1996; 27(1):19-29. PubMed ID: 8625944
[TBL] [Abstract][Full Text] [Related]
15. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 12. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICPEMC Expert Group on Antimutagens and Desmutagens.
Ramel C; Alekperov UK; Ames BN; Kada T; Wattenberg LW
Mutat Res; 1986 Jul; 168(1):47-65. PubMed ID: 3520303
[No Abstract] [Full Text] [Related]
16. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 5/6. Perspectives in mutation epidemiology, 6. A 1983 view of sentinel phenotypes.
Mulvihill JJ; Czeizel A
Mutat Res; 1983 Dec; 123(3):345-61. PubMed ID: 6358880
[TBL] [Abstract][Full Text] [Related]
17. International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.
Atherosclerosis; 1991 Aug; 89(2-3):255-61. PubMed ID: 1793453
[No Abstract] [Full Text] [Related]
18. Mutation epidemiology: review and recommendations. A report to the International Commission for Protection against Environmental Mutagens and Carcinogens by Committee 5 (Epidemiology).
Mutat Res; 1983 Sep; 123(1):1-11. PubMed ID: 6888411
[No Abstract] [Full Text] [Related]
19. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/5. Perspectives in mutation epidemiology. 5. Modern medical practice versus environmental mutagens: their possible dysgenic impact.
Matsunaga E
Mutat Res; 1983 Apr; 114(3):449-57. PubMed ID: 6835245
[TBL] [Abstract][Full Text] [Related]
20. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 5/4. Perspectives in mutation epidemiology: 4. General principles and considerations.
Miller JR
Mutat Res; 1983 Apr; 114(3):425-47. PubMed ID: 6835244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
